31 completed, 9 terminated, 9 unknown, 5 withdrawn. 19 Phase 2, 11 Not applicable, 8 Phase 3, 4 Phase 4, 3 Phase 1.
Follow Exanthema: new trials by email Literature Review of Exanthema trials Research Report on Exanthema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Wucao Anfu Formula as Adjunctive Treatment for Immune Checkpoint Inhibitor-Related Rash Wucao Anfu Formula, Standard management - Immune Checkpoint Inhibitor-related Rash, Immune-related Adverse Events | Not applicable | Not yet recruiting | First Teaching Hospital of Tianjin University of Traditional Chinese Medicine | 72 | 2026-09-05 | 2026-09-15 |
| Rash & Diarrhea Prophylaxis With Capivasertib Capivasertib, Loperamide, Fulvestrant - Metastatic HR+/HER2- Breast Cancer | Phase 2 | Recruiting | Maryam Lustberg | 108 | 2026-08-15 | 2026-07-29 |
| Telemedicine Rash Evaluation and Assessment of Toxicity in Skin in Acute Oncology and Haematology Care: A Pilot Study telem healthassessment - Rash, Systemic Treatments | Not applicable | Enrolling by invitation | Sligo General Hospital | 25 | 2026-04-01 | 2026-04-28 |
| A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis Deucravacitinib, Placebo - Plaque Psoriasis | Phase 3 | Recruiting | Bristol-Myers Squibb | 366 | 2025-12-03 | 2026-09-03 |
| Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections Exanthema, Dengue Fever | Not yet recruiting | Hospital Israelita Albert Einstein | 830 | 2025-09-01 | 2025-08-08 | |
| SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS) | Recruiting | Leiden University Medical Center | 840 | 2025-07-29 | 2025-08-19 | |
| Topical Ruxolitinib Evaluation in Immune-related Lichenoid Skin-Toxicities Ruxolitinib Topical Cream - Exanthema, Lichenoid Skin Rashes Under Anti-PD1 Tumor Therapy | Phase 2 | Active not recruiting | University of Zurich | 22 | 2024-10-10 | 2026-04-30 |
| Cardamom and Topical Roseomonas in Atopic Dermatitis Roseomonas mucosa (RSM2015) and Cardamom seeds, Placebo (sucrose) - Atopic Dermatitis, Eczema | Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 120 | 2024-10-09 | 2026-08-13 |
| The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction Dupilumab - Dermal Hypersensitivity Reaction | Phase 4 | Completed | University of Michigan | 10 | 2023-10-02 | 2026-01-12 |
| A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer Benralizumab, fulvestrant or AIs) and PI3K inhibition (alpelisib) - Breast Cancer | Phase 2 | Terminated | Memorial Sloan Kettering Cancer Center | 1 | 2023-07-06 | 2024-08-29 |
| Clinical Study for the Efficacy Evaluation of a Food Supplement Mentha Suaveolens extract incorporated into a food supplement, Placebo product - Spot Pigmented, Wrinkle | Not applicable | Completed | Mibelle Group Biochemistry | 110 | 2023-06-21 | 2024-06-12 |
| GI Symptoms in Infants Fed Goat Milk-based Infant Formula Stool Assessment, Skin Rash | Completed | Ausnutria Hyproca B.V. | 425 | 2022-06-01 | 2025-01-01 | |
| Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% Fexofenadine Hydrochloride Topical Lotion 1% (OP2101) - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 1 | Completed | OrchestratePharma GmbH | 12 | 2022-04-01 | 2023-03-29 |
| Annurca Apple Peel Oleolite for the Treatment of Skin Hyperpigmentation Annurca apple oleolite, Placebo - Hyperpigmentation, Melasma | Not applicable | Completed | Ritamaria Di Lorenzo | 48 | 2022-02-01 | 2025-06-27 |
| Evaluation of Parents' Knowledge About Infant Teething Signs and Symptoms | Completed | Istanbul University | 108 | 2021-12-23 | 2024-07-29 | |
| Evaluation of a Cosmetic Product to Preserve Skin Conditions When Using Anti-EGFR Cancer Therapies Application of Onco-Rash cream, Application of Onco-Neutre cream - Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms | Not applicable | Unknown | Hospices Civils de Lyon | 96 | 2021-06-01 | 2021-05-07 |
| The Relationship Between Body Mass Index, Dental Eruption and Dental Caries Prevalence in School Children BMI determination, Eruption Time Assessment, Caries Assessment - Body Mass Index, Dental Caries | Unknown | Al-Azhar University | 1224 | 2021-04-21 | 2023-06-15 | |
| Molecular Mechanisms of Tooth Eruption Tooth extraction - Tooth Eruption | Unknown | University Hospital, Strasbourg, France | 50 | 2021-03-01 | 2021-03-30 | |
| Implementation of a Minor Ailment Service in Community Pharmacy Practice Minor ailment service - Acne, Bites | Not applicable | Completed | Universidad de Granada | 20987 | 2020-10-01 | 2023-12-07 |
| Study of Prevalence and Risk Factors of Hypovitaminosis C in Long Term Care Unit Blood sample - Vitamin C Deficiency, Scurvy | Not applicable | Completed | Hospices Civils de Lyon | 100 | 2019-01-31 | 2025-09-03 |
Showing 20 of 62. Sign in to see all of them.
Pruritus (8) · Colorectal Neoplasms (6) · Dermatitis (5) · Dermatitis, Atopic (5) · Eczema (5) · Urticaria (5) · Hypersensitivity (4) · Lung Neoplasms (4) · Carcinoma, Non-Small-Cell Lung (3) · Dental Caries (3) · Erythema (3) · Fever (3) · Head and Neck Neoplasms (3) · Neoplasms (3)
Skin and Connective Tissue Diseases (62) · Skin Diseases (60) · Pathological Conditions, Signs and Symptoms (22) · Signs and Symptoms (19) · Neoplasms (16) · Neoplasms by Site (13) · Digestive System Diseases (12) · Gastrointestinal Diseases (12) · Immune System Diseases (10) · Skin Manifestations (10) · Digestive System Neoplasms (8) · Gastrointestinal Neoplasms (8) · Intestinal Diseases (8) · Respiratory Tract Diseases (8) · Colonic Diseases (7)
Dapsone (2) · Doxycycline (2) · Exercise (2) · Fulvestrant (2) · Gels (2) · Prednisone (2) · Tooth Extraction (2) · Abatacept (1) · Acitretin (1) · Alpelisib (1) · Anti-Bacterial Agents (1) · Blood Specimen Collection (1) · Cetuximab (1) · Clindamycin (1) · Erlotinib Hydrochloride (1)
Northwestern University (3) · Amgen (2) · Hospices Civils de Lyon (2) · Memorial Sloan Kettering Cancer Center (2) · Merz North America, Inc. (2) · Novartis Pharmaceuticals (2) · Al-Azhar University (1) · Allergan (1) · Asan Medical Center (1) · Aucta Pharmaceuticals, Inc (1) · Ausnutria Hyproca B.V. (1) · Bamrasnaradura Infectious Diseases Institute (1) · Bristol-Myers Squibb (1) · British Columbia Cancer Agency (1) · Cairo University (1)
United States (21) · France (5) · Canada (3) · Italy (3) · Netherlands (3) · United Kingdom (3) · Brazil (2) · China (2) · Germany (2) · Hungary (2) · Ireland (2) · Mexico (2) · Poland (2) · Spain (2) · Argentina (1)
Mario Lacouture, MD (4) · Michael Kuligowski, MD, PhD, MBA (2) · Alaa Nabil Abbas, PHD (1) · Alexander Gluzman, MD (1) · Alexey V Danilov, MD (1) · Alina Markova, MD (1) · Ann K Sullivan, MBBS FRCP (1) · Ayala Hubert, MD (1) · Bahar Tuna, Prof.Dr (1) · Barb Melosky, MD (1) · Carl Christoph Schimanski, PD Dr. med. (1)
PMID 19494218, PMID 20732960, PMID 22000810, PMID 22070868, PMID 23417565, PMID 25029335, PMID 25223501, PMID 25882778, PMID 26111953, PMID 26573073, PMID 27269295, PMID 27474763, PMID 28118536, PMID 28476259, PMID 30607677, PMID 32589310, PMID 33378508, PMID 34967448, PMID 39935845, PMID 41351479
2023 (2), 2008 (1)